| |
| |
|
| Insider
Information: |
Haughey Thomas |
| Relationship: |
Director |
| City: |
Woodcliff Lake |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
47,116 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,161,955 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
47,116 |
|
|
| Total
Value |
$3,161,955 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
0.0
|
| Percentage
Gain/Loss : |
 -27.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Par Pharmaceutical Companies Inc |
PRX |
President, Director |
2012-09-28 |
0 |
2012-09-28 |
0 |
Premium* |
|
|
ANI Pharmaceuticals Inc |
ANIP |
Director |
2023-05-23 |
47,116 |
2018-06-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANIP |
ANI Pharmaceuticals Inc |
Director |
– • – |
2023-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
6,865 |
47,116 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
|
– • – |
2022-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
10,049 |
40,251 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
|
– • – |
2021-12-06 |
4 |
B |
$39.38 |
$98,450 |
D/D |
2,500 |
30,202 |
0.01 |
% |
|
| ANIP |
ANI Pharmaceuticals Inc |
|
– • – |
2021-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
9,292 |
27,702 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
Director |
– • – |
2020-04-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,119 |
18,410 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
Director |
– • – |
2020-03-04 |
4 |
B |
$45.05 |
$135,150 |
D/D |
3,000 |
11,291 |
2.39 |
% |
|
| ANIP |
ANI Pharmaceuticals Inc |
Director |
– • – |
2020-03-03 |
4 |
B |
$45.18 |
$90,360 |
D/D |
2,000 |
8,291 |
2.39 |
% |
|
| ANIP |
ANI Pharmaceuticals Inc |
Director |
– • – |
2019-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,991 |
3,791 |
0 |
- |
|
| ANIP |
ANI Pharmaceuticals Inc |
Director |
– • – |
2018-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,800 |
1,800 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
President |
• • – |
2012-09-28 |
4 |
D |
$50.00 |
$45,000 |
I/I |
(900) |
0 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
President |
• • – |
2012-09-28 |
4 |
D |
$50.00 |
$3,482,400 |
D/D |
(69,648) |
0 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
President |
• – – |
2012-01-11 |
4 |
D |
$35.65 |
$36,256 |
D/D |
(1,017) |
69,648 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
President |
• – – |
2012-01-06 |
4 |
D |
$34.01 |
$25,303 |
D/D |
(744) |
70,665 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
President |
• – – |
2012-01-04 |
4 |
D |
$32.17 |
$34,004 |
D/D |
(1,057) |
71,409 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
President |
• – – |
2011-11-21 |
4 |
D |
$29.56 |
$194,771 |
D/D |
(6,589) |
72,466 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-05-10 |
4 |
S |
$35.45 |
$952,727 |
D/D |
(26,800) |
79,055 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-05-10 |
4 |
OE |
$13.06 |
$350,008 |
D/D |
26,800 |
105,855 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-05-09 |
4 |
OE |
$10.99 |
$753,815 |
D/D |
68,591 |
185,648 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-05-09 |
4 |
S |
$34.47 |
$3,447 |
D/D |
(100) |
84,455 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-05-09 |
4 |
S |
$34.45 |
$3,720,200 |
D/D |
(106,493) |
79,055 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-03-22 |
4 |
D |
$29.00 |
$88,856 |
D/D |
(3,064) |
117,057 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-01-11 |
4 |
D |
$35.98 |
$714,743 |
D/D |
(19,865) |
120,097 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
21,603 |
139,962 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-01-06 |
4/A |
A |
$0.00 |
$0 |
D/D |
8,894 |
118,383 |
0 |
- |
|
| PRX |
Par Pharmaceutical Compan... |
EVP, CAO, General Counsel |
• – – |
2011-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
8,870 |
118,359 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
